BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16925569)

  • 1. Pharmacodynamics of rituximab in kidney allotransplantation.
    Genberg H; Hansson A; Wernerson A; Wennberg L; Tydén G
    Am J Transplant; 2006 Oct; 6(10):2418-28. PubMed ID: 16925569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of rituximab in kidney transplantation.
    Genberg H; Hansson A; Wernerson A; Wennberg L; Tydén G
    Transplantation; 2007 Dec; 84(12 Suppl):S33-6. PubMed ID: 18162986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    Zarkhin V; Li L; Kambham N; Sigdel T; Salvatierra O; Sarwal MM
    Am J Transplant; 2008 Dec; 8(12):2607-17. PubMed ID: 18808404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
    Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
    Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.
    Lehnhardt A; Mengel M; Pape L; Ehrich JH; Offner G; Strehlau J
    Am J Transplant; 2006 Apr; 6(4):847-51. PubMed ID: 16539643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil.
    Kabei K; Uchida J; Iwai T; Yamasaki T; Kuwabara N; Naganuma T; Kumada N; Nakatani T
    Transpl Immunol; 2014 Aug; 31(2):92-7. PubMed ID: 24932811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in pediatric renal transplantation: a treatment for allograft rejection with B-cell infiltrates?
    Zand MS
    Am J Transplant; 2008 Dec; 8(12):2489-90. PubMed ID: 19032220
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.
    Kamburova EG; Koenen HJ; Borgman KJ; ten Berge IJ; Joosten I; Hilbrands LB
    Am J Transplant; 2013 Jun; 13(6):1503-11. PubMed ID: 23570303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation.
    Tydén G; Genberg H; Tollemar J; Ekberg H; Persson NH; Tufveson G; Wadström J; Gäbel M; Mjörnstedt L
    Transplantation; 2009 May; 87(9):1325-9. PubMed ID: 19424032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in highly sensitized kidney transplant recipients.
    Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
    Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
    PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate.
    Vega J; Goecke H; Carrasco A; Escobar C; Escobar M; Espinosa R; Méndez G; de Los Ángeles Rodríguez M
    Clin Exp Nephrol; 2011 Apr; 15(2):308-11. PubMed ID: 21152944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection.
    Steinmetz OM; Lange-Hüsken F; Turner JE; Vernauer A; Helmchen U; Stahl RA; Thaiss F; Panzer U
    Transplantation; 2007 Oct; 84(7):842-50. PubMed ID: 17984836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell monitoring of transplant patients treated with anti-CD20.
    Abdallah KO; Prak ET
    Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion.
    Kayler LK; Lakkis FG; Morgan C; Basu A; Blisard D; Tan HP; McCauley J; Wu C; Shapiro R; Randhawa PS
    Am J Transplant; 2007 Apr; 7(4):949-54. PubMed ID: 17331114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
    Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.